Characteristics of ATP-induced current through P2X7 receptor in NG108-15 cells: unique antagonist sensitivity and lack of pore formation
- PMID: 12046986
- DOI: 10.1254/jjp.88.428
Characteristics of ATP-induced current through P2X7 receptor in NG108-15 cells: unique antagonist sensitivity and lack of pore formation
Abstract
ATP activates the mouse P2X7 receptor and induces a nonselective-cation current in NG108-15 cells. We investigated the effects of five receptor antagonists on the ATP-induced nonselective-cation current through P2X7 receptor (I(NS.P2X7)) in NG108-15 cells. Nonselective P2 receptor antagonists, RB-2, PPADS and suramin inhibited the I(NS.P2X7) with IC50 values of 4.3, 53 and 40 microM, respectively. However, KN-04, which is a potent antagonist of human P2X7 receptors but is not that of rat P2X7 receptors, had only a weak blocking effect. Furthermore, oxidized-ATP (300 microM), an antagonist of the P2X7 receptor-mediated pore-formation, did not affect the I(NS.P2X7). Prolonged ATP application did not increase the membrane permeability to large molecules, N-methyl-D-glucamine or Yo-Pro-1, indicating that pore-formation was not promoted by the P2X7 receptor activation in NG108-15 cells. These results suggest that antagonist sensitivities and pore-forming properties of the P2X7 receptors in NG108-15 cells are different from those of other cells types.
Similar articles
-
Complexities of measuring antagonist potency at P2X(7) receptor orthologs.J Pharmacol Exp Ther. 2001 Mar;296(3):947-57. J Pharmacol Exp Ther. 2001. PMID: 11181928
-
Antagonist effects on human P2X(7) receptor-mediated cellular accumulation of YO-PRO-1.Br J Pharmacol. 2000 Jun;130(3):513-20. doi: 10.1038/sj.bjp.0703368. Br J Pharmacol. 2000. PMID: 10821778 Free PMC article.
-
Pharmacological characterization of the P2X(7) receptor on human macrophages using the patch-clamp technique.Naunyn Schmiedebergs Arch Pharmacol. 2002 Feb;365(2):168-71. doi: 10.1007/s00210-001-0501-2. Epub 2001 Nov 22. Naunyn Schmiedebergs Arch Pharmacol. 2002. PMID: 11819036
-
Agonists and antagonists acting at P2X7 receptor.Curr Top Med Chem. 2004;4(16):1707-17. doi: 10.2174/1568026043387223. Curr Top Med Chem. 2004. PMID: 15579103 Review.
-
Untangling Macropore Formation and Current Facilitation in P2X7.Int J Mol Sci. 2023 Jun 30;24(13):10896. doi: 10.3390/ijms241310896. Int J Mol Sci. 2023. PMID: 37446075 Free PMC article. Review.
Cited by
-
P2X and P2Y receptors—role in the pathophysiology of the nervous system.Int J Mol Sci. 2014 Dec 18;15(12):23672-704. doi: 10.3390/ijms151223672. Int J Mol Sci. 2014. PMID: 25530618 Free PMC article. Review.
-
Purinergic signalling and cancer.Purinergic Signal. 2013 Dec;9(4):491-540. doi: 10.1007/s11302-013-9372-5. Purinergic Signal. 2013. PMID: 23797685 Free PMC article. Review.
-
Large-conductance channel formation mediated by P2X7 receptor activation is regulated through distinct intracellular signaling pathways in peritoneal macrophages and 2BH4 cells.Naunyn Schmiedebergs Arch Pharmacol. 2010 Jul;382(1):73-87. doi: 10.1007/s00210-010-0523-8. Epub 2010 May 28. Naunyn Schmiedebergs Arch Pharmacol. 2010. PMID: 20508916
-
Tumour immune escape via P2X7 receptor signalling.Front Immunol. 2023 Oct 30;14:1287310. doi: 10.3389/fimmu.2023.1287310. eCollection 2023. Front Immunol. 2023. PMID: 38022596 Free PMC article. Review.
-
Antagonism of the ATP-gated P2X7 receptor: a potential therapeutic strategy for cancer.Purinergic Signal. 2021 Jun;17(2):215-227. doi: 10.1007/s11302-021-09776-9. Epub 2021 Mar 17. Purinergic Signal. 2021. PMID: 33728582 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous